| BRIUX | CSRIX | BRIUX / CSRIX | |
| Total Expense Ratio | 0.80 | 0.75 | 107% |
| Annual Report Gross Expense Ratio | 0.90 | 0.76 | 118% |
| Fund Existence | 8 years | 26 years | - |
| Gain YTD | 4.916 | 4.115 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 1000000 | 500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 266M | 7.92B | 3% |
| Annual Yield % from dividends | 1.66 | 3.09 | 54% |
| Returns for 1 year | 1.07 | -2.84 | -38% |
| Returns for 3 years | 35.86 | 17.70 | 203% |
| Returns for 5 years | 34.57 | 28.82 | 120% |
| Returns for 10 years | N/A | 38.59 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HSLCX | 44.38 | 0.72 | +1.65% |
| Hartford Small Cap Growth C | |||
| CRFIX | 12.93 | 0.10 | +0.78% |
| Calvert Focused Value I | |||
| PGLRX | 19.16 | 0.13 | +0.68% |
| Putnam Focused International Equity R | |||
| PACOX | 67.63 | 0.16 | +0.24% |
| T. Rowe Price U.S. Equity Research Adv | |||
| GERAX | 11.17 | N/A | N/A |
| Goldman Sachs Em Mkts Eq Insghts A | |||